美国和德国药物短缺的比较分析 (2016 - 2023)
Emanuel Nussli1, Miquel Serra-Burriel1, Kerstin N Vokinger1
1UNIVERSITY OF ZURICH, ZURICH, SWITZERLAND.
概括
这项研究比较了2016-2023年美国和德国的药物短缺趋势,检查了活性物质,持续时间和循环模式,以确定制药供应链中的关键相似性和差异.
科学领域:
- 制药科学 制药科学
- 卫生经济学 卫生经济学
- 公共卫生政策 公共卫生政策
背景情况:
- 药物短缺对全球医疗保健系统构成重大挑战.
- 了解国际趋势对于有效的供应链管理至关重要.
- 美国和德国代表着具有不同的监管环境的主要制药市场.
研究的目的:
- 分析和比较2016年至2023年间美国和德国药物短缺趋势.
- 根据活性物质,持续时间和周期性模式,确定药物短缺的共同点和差异.
- 为减轻未来制药供应链中断的政策和实践提供信息.
主要方法:
- 美国和德国药物短缺数据的比较分析.
- 检查与缺乏的特定活性药物成分 (API) 相关的趋势.
- 在研究期间评估药物短缺的持续时间和周期性.
主要成果:
- 确定了在两国经常出现短缺的特定活性物质.
- 美国和德国之间药物短缺平均持续时间的量化差异.
- 揭示了药物短缺的明显和重叠的循环趋势,表明了各种各样的因素.
结论:
- 药物短缺既具有共同特征,也具有国家特征.
- 对比分析为提高制药供应链弹性提供了有价值的见解.
- 政策干预可能需要量身定制,以应对影响药物可用性的国内和国际因素.
相关概念视频
Prescription, Nonprescription and Orphan Drugs
699
Prescription drugs require a prescription from a medical practitioner and can only be obtained from a pharmacy. They have many applications, including treating pain, anxiety, and hypertension.
The misuse and addiction to prescription drugs is a growing problem that can affect people of all age groups, specifically teenagers. This can happen when prescription medications are used in ways not intended by the prescriber, such as taking someone else's prescription or using medication for...
The misuse and addiction to prescription drugs is a growing problem that can affect people of all age groups, specifically teenagers. This can happen when prescription medications are used in ways not intended by the prescriber, such as taking someone else's prescription or using medication for...
699
Drug Regulation
1.3K
Drug regulation encompasses the management of drug usage by evaluating its safety and efficacy through assessments conducted by regulatory authorities. Regrettably, the history of drug regulation is marred by several catastrophic events. One such incident is the Elixir Sulfanilamide tragedy, in which the toxic compound diethyl glycol was included in a sweet-tasting medication, leading to numerous fatalities. This event prompted the enactment of the Food, Drug, and Cosmetic Act in 1938. Under...
1.3K
Analysis of Population Pharmacokinetic Data
235
Analysis of population pharmacokinetic data involves studying the behavior of drugs within diverse populations to understand their pharmacokinetic parameters. Traditional pharmacokinetic methods typically involve collecting samples from a few individuals and estimating these parameters. While these methods are commonly used, they have limitations in capturing the variability in drug response among individuals or heterogeneous populations. Population pharmacokinetics is employed to address these...
235
Drug Control Governance: Regulatory Bodies and Their Impact
144
Drug control governance involves the oversight and regulation of pharmaceuticals to ensure their safety and efficacy while preventing illegal drug use and trafficking. Regulatory bodies, including the US Food and Drug Administration (FDA) and the European Union's European Medicines Agency (EMA), play a central role in this process. These agencies evaluate the safety and efficacy of drugs before they can be marketed. They fund clinical trials and assess the benefits and risks associated with...
144
Drug Concentrations: Measurements
336
Drug concentration is the quantity of a drug present in a biological sample. Measuring drug amounts in biological samples allows the clinician to understand how a drug is absorbed, distributed, metabolized, and excreted. Samples can be obtained through invasive or non-invasive methods. Invasive techniques involve surgical or parenteral interventions to gather blood, cerebrospinal fluid, or tissue biopsy. Conversely, non-invasive approaches provide samples like urine, feces, and saliva.
Plasma...
Plasma...
336
Model-Independent Approaches for Pharmacokinetic Data: Noncompartmental Analysis
49
Noncompartmental analyses offer an alternative method for describing drug pharmacokinetics without relying on a specific compartmental model. In this approach, the drug's pharmacokinetics are assumed to be linear, with the terminal phase log-linear. This assumption allows for simplified analysis and interpretation of the drug's behavior in the body.
One important characteristic of noncompartmental analyses is that drug exposure increases proportionally with increasing doses. This...
One important characteristic of noncompartmental analyses is that drug exposure increases proportionally with increasing doses. This...
49


